MapLight Therapeutics Stock

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Sign up today and learn more about MapLight Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About MapLight Therapeutics Stock

MapLight Therapeutics offers a platform designed to discover and develop therapeutics for brain disorders. It combines single-cell transcriptomics and optogenetics to identify novel drug targets and develop effective therapies for brain disorders.

Funding History

March 2019$5.0M
November 2020$8.1M
March 2021$30.0M
October 2023$225M

Management

Co-Founder

Karoly Nikolich

Co-Founder & CEO

Chris Kroeger

Co-Founder

Karl Deisseroth

Co-Founder

Robert Malenka

Chief Scientific Officer

James Lillie

Board Member

Jim Trenkle

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo